Literature DB >> 24464287

Similarity network fusion for aggregating data types on a genomic scale.

Bo Wang1, Aziz M Mezlini2, Feyyaz Demir2, Marc Fiume3, Zhuowen Tu4, Michael Brudno2, Benjamin Haibe-Kains5, Anna Goldenberg2.   

Abstract

Recent technologies have made it cost-effective to collect diverse types of genome-wide data. Computational methods are needed to combine these data to create a comprehensive view of a given disease or a biological process. Similarity network fusion (SNF) solves this problem by constructing networks of samples (e.g., patients) for each available data type and then efficiently fusing these into one network that represents the full spectrum of underlying data. For example, to create a comprehensive view of a disease given a cohort of patients, SNF computes and fuses patient similarity networks obtained from each of their data types separately, taking advantage of the complementarity in the data. We used SNF to combine mRNA expression, DNA methylation and microRNA (miRNA) expression data for five cancer data sets. SNF substantially outperforms single data type analysis and established integrative approaches when identifying cancer subtypes and is effective for predicting survival.

Entities:  

Mesh:

Year:  2014        PMID: 24464287     DOI: 10.1038/nmeth.2810

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  17 in total

1.  Network medicine--from obesity to the "diseasome".

Authors:  Albert-László Barabási
Journal:  N Engl J Med       Date:  2007-07-25       Impact factor: 91.245

2.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data.

Authors:  Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan
Journal:  Genome Res       Date:  2007-10-05       Impact factor: 9.043

3.  Point: Are we prepared for the future doctor visit?

Authors:  Stephen H Friend; Trey Ideker
Journal:  Nat Biotechnol       Date:  2011-03       Impact factor: 54.908

4.  Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

Authors:  Janice M Nigro; Anjan Misra; Li Zhang; Ivan Smirnov; Howard Colman; Chandi Griffin; Natalie Ozburn; Mingang Chen; Edward Pan; Dimpy Koul; W K Alfred Yung; Burt G Feuerstein; Kenneth D Aldape
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

5.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Authors:  Dominik Sturm; Hendrik Witt; Volker Hovestadt; Dong-Anh Khuong-Quang; David T W Jones; Carolin Konermann; Elke Pfaff; Martje Tönjes; Martin Sill; Sebastian Bender; Marcel Kool; Marc Zapatka; Natalia Becker; Manuela Zucknick; Thomas Hielscher; Xiao-Yang Liu; Adam M Fontebasso; Marina Ryzhova; Steffen Albrecht; Karine Jacob; Marietta Wolter; Martin Ebinger; Martin U Schuhmann; Timothy van Meter; Michael C Frühwald; Holger Hauch; Arnulf Pekrun; Bernhard Radlwimmer; Tim Niehues; Gregor von Komorowski; Matthias Dürken; Andreas E Kulozik; Jenny Madden; Andrew Donson; Nicholas K Foreman; Rachid Drissi; Maryam Fouladi; Wolfram Scheurlen; Andreas von Deimling; Camelia Monoranu; Wolfgang Roggendorf; Christel Herold-Mende; Andreas Unterberg; Christof M Kramm; Jörg Felsberg; Christian Hartmann; Benedikt Wiestler; Wolfgang Wick; Till Milde; Olaf Witt; Anders M Lindroth; Jeremy Schwartzentruber; Damien Faury; Adam Fleming; Magdalena Zakrzewska; Pawel P Liberski; Krzysztof Zakrzewski; Peter Hauser; Miklos Garami; Almos Klekner; Laszlo Bognar; Sorana Morrissy; Florence Cavalli; Michael D Taylor; Peter van Sluis; Jan Koster; Rogier Versteeg; Richard Volckmann; Tom Mikkelsen; Kenneth Aldape; Guido Reifenberger; V Peter Collins; Jacek Majewski; Andrey Korshunov; Peter Lichter; Christoph Plass; Nada Jabado; Stefan M Pfister
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

6.  Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer.

Authors:  Adam A Margolin; Erhan Bilal; Erich Huang; Thea C Norman; Lars Ottestad; Brigham H Mecham; Ben Sauerwine; Michael R Kellen; Lara M Mangravite; Matthew D Furia; Hans Kristian Moen Vollan; Oscar M Rueda; Justin Guinney; Nicole A Deflaux; Bruce Hoff; Xavier Schildwachter; Hege G Russnes; Daehoon Park; Veronica O Vang; Tyler Pirtle; Lamia Youseff; Craig Citro; Christina Curtis; Vessela N Kristensen; Joseph Hellerstein; Stephen H Friend; Gustavo Stolovitzky; Samuel Aparicio; Carlos Caldas; Anne-Lise Børresen-Dale
Journal:  Sci Transl Med       Date:  2013-04-17       Impact factor: 17.956

7.  Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis.

Authors:  Ronglai Shen; Adam B Olshen; Marc Ladanyi
Journal:  Bioinformatics       Date:  2009-09-16       Impact factor: 6.937

8.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

9.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

10.  Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.

Authors:  Wei Zhang; Takayo Ota; Viji Shridhar; Jeremy Chien; Baolin Wu; Rui Kuang
Journal:  PLoS Comput Biol       Date:  2013-03-21       Impact factor: 4.475

View more
  400 in total

1.  A novel approach to multiple anatomical shape analysis: Application to fetal ventriculomegaly.

Authors:  Oualid Benkarim; Gemma Piella; Islem Rekik; Nadine Hahner; Elisenda Eixarch; Dinggang Shen; Gang Li; Miguel Angel González Ballester; Gerard Sanroma
Journal:  Med Image Anal       Date:  2020-06-10       Impact factor: 8.545

2.  Alternating Diffusion Map Based Fusion of Multimodal Brain Connectivity Networks for IQ Prediction.

Authors:  Li Xiao; Julia M Stephen; Tony W Wilson; Vince D Calhoun; Yu-Ping Wang
Journal:  IEEE Trans Biomed Eng       Date:  2018-11-29       Impact factor: 4.538

3.  Integrative construction of regulatory region networks in 127 human reference epigenomes by matrix factorization.

Authors:  Dianbo Liu; Jose Davila-Velderrain; Zhizhuo Zhang; Manolis Kellis
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

4.  Graph- and rule-based learning algorithms: a comprehensive review of their applications for cancer type classification and prognosis using genomic data.

Authors:  Saurav Mallik; Zhongming Zhao
Journal:  Brief Bioinform       Date:  2020-03-23       Impact factor: 11.622

Review 5.  Integrating phenotypic small-molecule profiling and human genetics: the next phase in drug discovery.

Authors:  Cory M Johannessen; Paul A Clemons; Bridget K Wagner
Journal:  Trends Genet       Date:  2014-12-12       Impact factor: 11.639

6.  MONET: Multi-omic module discovery by omic selection.

Authors:  Nimrod Rappoport; Roy Safra; Ron Shamir
Journal:  PLoS Comput Biol       Date:  2020-09-15       Impact factor: 4.475

7.  Molecular classification and subtype-specific drug sensitivity research of uterine carcinosarcoma under multi-omics framework.

Authors:  Xiaofan Lu; Liya Zhang; Huiling Zhao; Chen Chen; Yaoyan Wang; Shengjie Liu; Xiao Lin; Yue Wang; Qianyuan Zhang; Tao Lu; Fangrong Yan
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

8.  Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma.

Authors:  Lei Huang; Sarah Garrett Injac; Kemi Cui; Frank Braun; Qi Lin; Yuchen Du; Huiyuan Zhang; Mari Kogiso; Holly Lindsay; Sibo Zhao; Patricia Baxter; Adesina Adekunle; Tsz-Kwong Man; Hong Zhao; Xiao-Nan Li; Ching C Lau; Stephen T C Wong
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

Review 9.  The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.

Authors:  Kivilcim Ozturk; Michelle Dow; Daniel E Carlin; Rafael Bejar; Hannah Carter
Journal:  J Mol Biol       Date:  2018-06-15       Impact factor: 5.469

10.  ESTIMATION OF SHAPE AND GROWTH BRAIN NETWORK ATLASES FOR CONNECTOMIC BRAIN MAPPING IN DEVELOPING INFANTS.

Authors:  Islem Rekik; Gang Li; Weili Lin; Dinggang Shen
Journal:  Proc IEEE Int Symp Biomed Imaging       Date:  2018-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.